Blog

Learn about NETs, NETosis and Nu.Q® NETs.

October 10, 2023

Share
Tweet
Share on Facebook
Share

Earlier this year, we attended International Symposium on Infections in the Critically Ill Patient (ISICIP), where members of our R&D and Business Development presented our Nu.Q^{^®} NETs test, a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.

Download our infographic to learn about NETs, NETosis, and the Nu.Q^{^®} NETs test.

Download

Poster & Publications
Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients
Poster & Publications
Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA

Learn about NETs, NETosis and Nu.Q® NETs.

Related Articles

Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients

Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

Contact